183 related articles for article (PubMed ID: 32207044)
41. The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.
Kanno H; Sato H; Yokoyama TA; Yoshizumi T; Yamada S
Int J Oncol; 2013 Mar; 42(3):881-6. PubMed ID: 23338840
[TBL] [Abstract][Full Text] [Related]
42. A pumpkin polysaccharide induces apoptosis by inhibiting the JAK2/STAT3 pathway in human hepatoma HepG2 cells.
Shen W; Chen C; Guan Y; Song X; Jin Y; Wang J; Hu Y; Xin T; Jiang Q; Zhong L
Int J Biol Macromol; 2017 Nov; 104(Pt A):681-686. PubMed ID: 28634059
[TBL] [Abstract][Full Text] [Related]
43. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
Park KR; Yun HM; Quang TH; Oh H; Lee DS; Auh QS; Kim EC
Oncotarget; 2016 Feb; 7(6):6960-71. PubMed ID: 26755649
[TBL] [Abstract][Full Text] [Related]
44. cAMP/PKA enhances interleukin-1β-induced interleukin-6 synthesis through STAT3 in glial cells.
Tanabe K; Kozawa O; Iida H
Cell Signal; 2016 Jan; 28(1):19-24. PubMed ID: 26527061
[TBL] [Abstract][Full Text] [Related]
45. The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance.
Park SY; Lee CJ; Choi JH; Kim JH; Kim JW; Kim JY; Nam JS
J Exp Clin Cancer Res; 2019 Sep; 38(1):399. PubMed ID: 31511084
[TBL] [Abstract][Full Text] [Related]
46. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
47. The Iron Chelator and Anticancer Agent Dp44mT Relieves Allergic Inflammation in Mice With Allergic Rhinitis.
Kim HY; Han NR; Kim HM; Jeong HJ
Inflammation; 2018 Oct; 41(5):1744-1754. PubMed ID: 29967928
[TBL] [Abstract][Full Text] [Related]
48. Nitidine chloride suppresses epithelial-mesenchymal transition and stem cell-like properties in glioblastoma by regulating JAK2/STAT3 signaling.
Jia M; Wang Y; Guo Y; Yu P; Sun Y; Song Y; Zhao L
Cancer Med; 2021 May; 10(9):3113-3128. PubMed ID: 33788424
[TBL] [Abstract][Full Text] [Related]
49. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
[TBL] [Abstract][Full Text] [Related]
50. Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types.
Moussa RS; Kovacevic Z; Richardson DR
Oncotarget; 2015 Oct; 6(30):29694-711. PubMed ID: 26335183
[TBL] [Abstract][Full Text] [Related]
51. MiR-18a-downregulated RORA inhibits the proliferation and tumorigenesis of glioma using the TNF-α-mediated NF-κB signaling pathway.
Jiang Y; Zhou J; Zhao J; Hou D; Zhang H; Li L; Zou D; Hu J; Zhang Y; Jing Z
EBioMedicine; 2020 Feb; 52():102651. PubMed ID: 32062354
[TBL] [Abstract][Full Text] [Related]
52. The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells.
Rao VA; Klein SR; Agama KK; Toyoda E; Adachi N; Pommier Y; Shacter EB
Cancer Res; 2009 Feb; 69(3):948-57. PubMed ID: 19176392
[TBL] [Abstract][Full Text] [Related]
53. Nimesulide inhibits the growth of human esophageal carcinoma cells by inactivating the JAK2/STAT3 pathway.
Liu JR; Wu WJ; Liu SX; Zuo LF; Wang Y; Yang JZ; Nan YM
Pathol Res Pract; 2015 Jun; 211(6):426-34. PubMed ID: 25724470
[TBL] [Abstract][Full Text] [Related]
54. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X
Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291
[TBL] [Abstract][Full Text] [Related]
55. MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells.
Liu L; Gaboriaud N; Vougogianopoulou K; Tian Y; Wu J; Wen W; Skaltsounis L; Jove R
Cancer Biol Ther; 2014 Feb; 15(2):178-84. PubMed ID: 24100507
[TBL] [Abstract][Full Text] [Related]
56. Dual-functionality of RASSF1A overexpression in A375 cells is mediated by activation of IL-6/STAT3 regulatory loop.
Yi M; Wang W; Chen S; Peng Y; Li J; Cai J; Zhou Y; Peng Q; Ban Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
Mol Biol Rep; 2018 Oct; 45(5):1277-1287. PubMed ID: 30074127
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of JAK2/STAT3 Signaling Pathway Suppresses Proliferation of Burkitt's Lymphoma Raji Cells via Cell Cycle Progression, Apoptosis, and Oxidative Stress by Modulating HSP70.
Xu NW; Chen Y; Liu W; Chen YJ; Fan ZM; Liu M; Li LJ
Med Sci Monit; 2018 Sep; 24():6255-6263. PubMed ID: 30194286
[TBL] [Abstract][Full Text] [Related]
58. Amorfrutin A inhibits TNF-α induced JAK/STAT signaling, cell survival and proliferation of human cancer cells.
Mi C; Ma J; Wang KS; Wang Z; Li MY; Li JB; Li X; Piao LX; Xu GH; Jin X
Immunopharmacol Immunotoxicol; 2017 Dec; 39(6):338-347. PubMed ID: 28879797
[TBL] [Abstract][Full Text] [Related]
59. Apigetrin inhibits gastric cancer progression through inducing apoptosis and regulating ROS-modulated STAT3/JAK2 pathway.
Sun Q; Lu NN; Feng L
Biochem Biophys Res Commun; 2018 Mar; 498(1):164-170. PubMed ID: 29408335
[TBL] [Abstract][Full Text] [Related]
60. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]